Passion for animal health

January 2017 saw our union with Sanofi’s animal health business, Merial. The combined Boehringer Ingelheim Animal Health Business Unit is the world’s second largest animal health operation, with over 10,000 employees, products available in more than 150 markets, and a global presence in 99 countries.

Dr Joachim Hasenmaier,
member of the board of managing directors with responsibility for animal health


The combined strength of Boehringer Ingelheim’s and Sanofi’s animal health organisations will improve our competitiveness in the animal health business, which is strategically important to our company. Complementary portfolios make our two businesses a perfect fit. Together, we can serve customers and partners even better by offering a broader range of health solutions in more countries, while continuing the excellent service delivery our customers expect.

The combined Animal Health team is committed to using our combined scale, resources and deep R&D capabilities to lead the industry in improving animal well-being. Welcoming Merial into the Boehringer Ingelheim family reflects our passion for animal health and commitment to making the industry even better at improving both human and animal health. We have combined two leading industry players with a common vision, which is to recognise the critical importance of serving animal health needs globally, with a focus on prevention. We know that when animals are healthy, humans are healthy too.

As a leader in vaccines and antiparasitics, we will continue our special focus on prevention while addressing the spectrum of treatment needs. We aim to develop new, effective medicines and diagnostics for diseases with high unmet medical needs. We will continue to invest in our existing market-leading positions in swine, equine and pets, while expanding our offering in cattle, poultry and other livestock.

We now have the increased expertise and resources to offer our customers more innovation and a wider set of products and services. We want to support farmers to raise and care for animals in a healthy, sustainable and financially viable way, which builds confidence with consumers.


We’re committed to helping companion animals live longer and better, as most owners today have lifelong emotional connections with their pets and consider them family members. As a family-owned business, we can take a long-term perspective to achieve this for the benefit of our employees and customers.

Boehringer Ingelheim is committed to ensuring a smooth transition and business continuity as the organisations integrate. A deeply experienced new leadership team drawn from both Boehringer Ingelheim and Merial backgrounds will steer the Business Unit’s strategy and bear out our commitment to customer and partner relationships and innovation in 2017 and beyond.